Rapid detection of Staphylococcus aureus strains having reduced susceptibility to vancomycin using a chemiluminescence-based drug-susceptibility test.

[1]  C. Ruef.  Epidemiology and Clinical Impact of Glycopeptide Resistance in Staphylococcus aureus , 2004, Infection.

[2]  S. Fridkin,et al.  Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997-2001. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  Yoshihiko Saito,et al.  Evaluation of a Novel Automated Chemiluminescent Assay System for Antimicrobial Susceptibility Testing , 2003, Journal of Clinical Microbiology.

[4]  F. Tenover,et al.  Cell Wall Thickening Is a Common Feature of Vancomycin Resistance in Staphylococcus aureus , 2003, Journal of Clinical Microbiology.

[5]  K. Hiramatsu.  Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance. , 2001, The Lancet. Infectious diseases.

[6]  L. Cui,et al.  Isolation in Brazil of Nosocomial Staphylococcus aureus With Reduced Susceptibility to Vancomycin , 2001, Infection Control & Hospital Epidemiology.

[7]  A. MacGowan,et al.  Evaluation of Current Methods for Detection of Staphylococci with Reduced Susceptibility to Glycopeptides , 2001, Journal of Clinical Microbiology.

[8]  M. Ikedo,et al.  Menadione‐Catalyzed O2– Production by Escherichia coli Cells: Application of Rapid Chemiluminescent Assay to Antimicrobial Susceptibility Testing , 2001, Microbiology and immunology.

[9]  C. Pai,et al.  Vancomycin-Intermediate Staphylococcus aureus in Korea , 2000, Journal of Clinical Microbiology.

[10]  O. Chesneau,et al.  Retrospective screening for heterogeneous vancomycin resistance in diverse Staphylococcus aureus clones disseminated in French hospitals. , 2000, The Journal of antimicrobial chemotherapy.

[11]  G. Edwards,et al.  Vancomycin-intermediate Staphylococcus aureus at a Scottish Hospital , 2000 .

[12]  C. Martín,et al.  First clinical isolate of vancomycin-intermediate Staphylococcus aureus in a French hospital , 1998, The Lancet.

[13]  F. Tenover,et al.  Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. , 1997, The Journal of antimicrobial chemotherapy.

[14]  Henderson Ar,et al.  Assessing test accuracy and its clinical consequences: a primer for receiver operating characteristic curve analysis. , 1993 .

[15]  R. Howe,et al.  The prevalence and mechanisms of vancomycin resistance in Staphylococcus aureus. , 2002, Annual review of microbiology.

[16]  Mary Jane Ferraro,et al.  Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : approved standard , 2000 .

[17]  K. Hiramatsu.  Vancomycin resistance in staphylococci. , 1998, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[18]  C. Watanakunakorn.  Mode of action and in-vitro activity of vancomycin. , 1984, The Journal of antimicrobial chemotherapy.

[19]  G. Martin.  Letter: Computer-assisted tomograpy and tuberous sclerosis. , 1976, Lancet.